DCF — GRAND ITASCA CLINIC AND HOSPITAL
Enterprise Value: $42.2M
🛡️ Public data only — no PHI permitted on this instance.
← DashboardPRFProfileMEMIC MemoBRGBridgeCIComp IntelSCNScenariosAIMLDCFDCFLBOLBOFIN3-StmtMKTMarketDENDenialRETReturnsLVRLeversWFLWaterfallPLYPlaybookTRDTrendsPREDPredictedMEM2Memo
$42.2M
Enterprise Value
$9.4M
PV of Cash Flows
$32.8M
PV of Terminal Value
$52.9M
Terminal Value
10.0%
WACC
2.5%
Terminal Growth
Cash Flow Projections
PROJ| Year | Revenue | EBITDA | Margin | FCF | PV(FCF) |
|---|---|---|---|---|---|
| Year 1 | $121.2M | $7.1M | 6.0% | $0.9M | $0.9M |
| Year 2 | $124.9M | $8.5M | 7.0% | $1.9M | $1.6M |
| Year 3 | $128.6M | $10.1M | 8.0% | $2.9M | $2.2M |
| Year 4 | $132.5M | $11.0M | 8.0% | $3.5M | $2.4M |
| Year 5 | $136.4M | $11.7M | 9.0% | $3.9M | $2.4M |
Interpretation
INTAt a WACC of 10.0% and terminal growth of 2.5%, enterprise value is $42.2M. Terminal value accounts for 78% of total EV — typical range (60-80%).
Next steps: Check the LBO model to see equity returns at this entry price, or the EBITDA bridge to model value creation levers.
Assumptions
ASSMrevenue base$117.7M
revenue growth rates[0.03, 0.03, 0.03, 0.03, 0.03]
ebitda margin base0.05341294597969665
ebitda margin improvement bps[50, 100, 100, 50, 25]
capex pct revenue0.04
nwc pct revenue0.08
tax rate0.25
projection years5